studying the role of magnesium on uremic osseous disease in patients on chroniohemodialysis we examined 50 patients with chrovic renal diseases , chronic renal insufficiency ( cri ) and chroniodialysis treatment ( cdt ) with duration of the dialysis treatment from i to 10 years , 3 years on the average , and compared it with control groups of 20 patients with chronic renal diseases without cri , with duration of the diseases from 3 to 22 years , 9 years on the average and 20 patients with chronic renal diseases and cri ( stage i -- iii ) on conservative treatment , with a duration of the cri from 0.5 to 6 years , 2 years on the average .
C0022658
renal diseases
C0022661
cri